{'fraction_non_alphanumeric': 0.01680672268907563, 'fraction_numerical': 0.008403361344537815, 'mean_word_length': 5.725806451612903, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Previous antiplatelet treatment and mortality in patients with intracerebral hemorrhage.

To the Editor:

Foerch et al1 reported that pretreatment with antiplatelet agents was not an independent risk factor of mortality and unfavourable outcome in patients with intracerebral hemorrhage (ICH). They studied 1691 patients with ICH and found that 26% of them were taking antiplatelet agents. Pretreatment with antiplatelet agents was a significant predictor of in-hospital mortality and unfavourable clinical outcome in the univariate logistic regression. However, after adjustment for age and prehospital status evaluated by the modified Rankin Scale, antiplatelet pretreatment was not an independent risk factor of in-hospital death.

Our group recently reported a detailed study demonstrating that previous antiplatelet therapy is …